Cladribine (Mavenclad®)

A Modification Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")

Source
Find a Tender
Type
Contract (Goods)
Duration
0.5 year
Value
£34M
Sector
HEALTH
Published
19 Aug 2022
Delivery
To 15 Feb 2023 (est.)
Deadline
n/a

Concepts

Location

Scotland:

Geochart for 1 buyers and 1 suppliers

1 buyer

1 supplier

Description

Total Quantity or Scope

This modification of contract term from 01/09/2022 to 28/02/2023 is to meet the additional demands of the Scottish Health and Social Care sector during the current Covid-19 pandemic and to maintain necessary supply and remove unnecessary disruption from the Authority at this time in line with Regulation 72(1)(b) of the Public Contracts (Scotland) Regulations 2015 Modification notice is advised at framework level and does not detail individual lots.

Award Detail

1 Merck Serono (Middlesex)
  • Cladribine (Mavenclad®)
  • Reference: 023054-2022-np91617 (b)-1
  • Value: £33,929,616

CPV Codes

  • 33600000 - Pharmaceutical products

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated value in Section V.2.4 covers the forty-eight (48) months of the framework length and six (6) months extension period of the framework agreement. (SC Ref:703561)

Reference

Domains